It's Time to Use MRD for Clinical Decision Making: MRD as a Surrogate Marker for PFS/OS, for Maintenance Decision Making, Renal Allografting Patient Qualification, and Solitary Plasmacytomas Definition
Login to view comments.
Click here to Login
